SAMDaily.us | MOD | Q | Single cell RNA Sequencing (SortSeq)

SAMDAILY.US - ISSUE OF JUNE 17, 2022 SAM #7504
MODIFICATION

Q -- Single cell RNA Sequencing (SortSeq)

Notice Date: 6/15/2022 3:05:30 PM
Notice Type: Combined Synopsis/Solicitation
NAICS: 621511 — Medical Laboratories
Contracting Office: NATIONAL INSTITUTES OF HEALTH NIDA Bethesda MD 20892 USA
ZIP Code: 20892
Solicitation Number: 75N95022Q00244
Response Due: 6/22/2022 7:00:00 AM
Archive Date: 07/07/2022
Point of Contact: fred Ettehadieh
E-Mail Address: fred.ettehadieh@nih.gov
(fred.ettehadieh@nih.gov)
Description: This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. (ii)�� The solicitation number is 75N95022Q00244 and the solicitation is issued as a request for quotation (RFQ). This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13�Simplified Acquisition Procedures-Simplified Procedures; and FAR Part 12�Acquisition of Commercial Items and is not expected to exceed the simplified acquisition threshold.� (iii)�� The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2022-06, with effective date May 26, 2022. (iv)�� The associated NAICS code 621511 and the small business size standard is $35 million. No set-aside restriction is applicable. (v)�� This requirement is for the following services: Single cell RNA Sequencing (SortSeq). (vi)�� The purpose of this acquisition is to perform single cell RNA sequence in hematopoietic stem cells (HSCs) to reveal the HSC changes with aging in human. HSCs normally reside in bone marrow (BM) but can be detected in the human peripheral blood (PB). PB HSCs are very scarce under steady-state conditions, and human HSC aging has not characterized as extensively. We have obtained human PB and BM samples through the Gestalt project to reveal the HSC difference between PB and BM, and the HSC changes with aging in human. (vii)�� Independently and not as an agent of the Government, the Contractor shall furnish all the necessary services, qualified personnel, material, equipment, and facilities, not otherwise provided by the Government as needed to provide pre-prepared 30 of 384 well plates to our lab. NIA will perform the plate sorting using human BM and PB samples, then the contractor shall generate genome library preparations from single-cell in 384 well plate. NIA have 8 plates remained in their pilot experiment. These 38 libraries will then be sequenced on an Illumina platform to 150,000 raw reads per cells. In order to complete the necessary side by side comparisons of previously obtained date with future data on this research project, it is imperative the new data seamlessly integrates into an existing data set. The contractor must be able to provide data that is completely harmonious with extant data. The contractor shall provide FASTQ files as a resultant read out of the libraries provided so the data can be analyzed in conjunction with prior library/sequencing generation. (viii)�� The Government anticipates award of a firm fixed-price purchase order for this acquisition. The anticipated period of performance is for 12 months. � (ix)�� The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb �� 1998), applies to this acquisition. This solicitation incorporates one or more solicitation �� provisions by reference, with the same force and effect as if they were given in full text. �� Upon request, the Contracting Officer will make their full text available. The offeror is �� cautioned that the listed provisions may include blocks that must be completed by the � � ��offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the �appropriate information with its quotation or offer. Also, the full text of a solicitation �� provision may be accessed electronically at these addresses:� https://www.acquisition.gov/browse/index/far ��https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html �� (End of provision) The following provisions apply to this acquisition and are incorporated by reference: FAR 52.204-7, System for Award Management (Oct 2018) FAR 52.204-16, Commercial and Government Entity Code Reporting (Aug 2020) FAR 52.211-6, Brand Name or Equal (Aug 1999) FAR 52.212-1, Instructions to Offerors-Commercial Items (Nov 2021) FAR 52.212-3, Offeror Representations and Certifications-Commercial Items (Nov 2021) HHSAR 352.239-73, Electronic and Information Technology Accessibility Notice (December 18, 2015) The clause at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998), applies to this acquisition. This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far ��https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html � (End of clause) The following clauses apply to this acquisition and are incorporated by reference: FAR 52.204-13, System for Award Management Maintenance (Oct 2018) FAR 52.204-18, Commercial and Government Entity Code Maintenance (Aug 2020) FAR 52.212-4, Contract Terms and Conditions--Commercial Items (Nov 2021) Addendum to this FAR clause applies to this acquisition and is attached. HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 18, 2015) HHSAR 352.239-74, Electronic and Information Technology Accessibility (December 18, 2015) The following provisions and clauses apply to this acquisition and are attached in full text.� Offerors MUST complete the provisions at 52.204-24 and 52.204-26 and submit completed copies as separate documents with their quote. FAR 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Nov 2021) FAR 52.204-26, Covered Telecommunications Equipment or Services-Representation (Oct 2020) FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders--Commercial Items (Jan 2022) The following invoice instructions are attached, however only one will be included in the final order: Invoicing Instructions With IPP 4-21-22 Invoicing Instructions Without IPP 4-21-22 (x)�� The provision at FAR clause 52.212-2, Evaluation � Commercial Items (Nov 2021), applies to this acquisition.� (a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers: (i) technical capability of the item offered to meet the Government requirement; (ii) past performance [see FAR 13.106-2(b)(3)]; (iii) price. Technical and past performance, when combined, are significantly more important than price. (b) A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer�s specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award. (xi)�� The Offerors to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications-Commercial Items (Nov 2021), with its offer. If the offeror has completed FAR clause 52.212-3 at www.sam.gov, then the offeror does not need to provide a completed copy with its offer. (xii)�� There are no additional contract requirement(s) or terms and conditions applicable to this acquisition. (xiii)�� The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. (xiv)�� Responses to this solicitation must include sufficient information to establish the interested parties� bona-fide capabilities of providing the product or service. The price quote shall include: unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, F.O.B. Point (Destination or Origin), product or catalog number(s), product description, and any other information or factors that may be considered in the award decision. Such factors may include: past performance, special features required for effective program performance, trade-in considerations, probable life of the item selected as compared with that of a comparable item, warranty considerations, maintenance availability, and environmental and energy efficiency considerations. Respondents proposing on an equal product of the brand-name product specified in this announcement must provide, as part of their response: (a) product, catalog, model, and/or part number(s); (b) product description; (c) all relevant information and documentation that the item(s) offered meets the salient physical, functional, or performance characteristics as specified in the purchase description; quantity; estimated price or cost; shipping, handling, and/or installation charges; and delivery date after receipt of order. The Unique Entity ID from SAM.gov, the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. All quotations from responsible sources must be submitted electronically (by email) to Fred Ettehadieh, Contracting Officer, at fred.ettehadieh@nih.gov by the closing date and time of this solicitation, and reference Solicitation number 75N95022Q00244. �Fax responses will not be accepted.
Web Link: SAM.gov Permalink
(https://sam.gov/opp/367f832630b549228a9a270b0630233d/view)
Place of Performance: Address: Baltimore, MD, USA; Country: USA
Record: SN06358666-F 20220617/220615230105 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |

Loren Data's SAM Daily™

Q -- Single cell RNA Sequencing (SortSeq)